ClinicalTrials.gg
RecruitingNCT05534282INMUTUpdated May 9, 2024

Music Therapy With Cancer Affected Children and Their Families

An interventional study of Interaction-focused Music Therapy with Children and Significant Others (INMUT-KB) (exp. group) and Music Therapy with Children (MUT-K) (exp. group) in Pediatric Cancer, sponsored by University of Witten/Herdecke. Recruiting at 3 sites in Germany. Open to participants aged 5 Years to 13 Years. Per ClinicalTrials.gov, last updated 2024-05-09.

Sponsored by University of Witten/Herdecke · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Aug 2024, 2 years 2 months ago, but the record still lists the study as recruiting.
  • Started Mar 2023; still recruiting 3 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
5 Years to 13 Years
Sex
All
01

Study summary

Background: Pediatric oncology patients and their families are in an existentially threatening situation for which music therapy has proven as a cross-linguistic field of action: the creative act of making music offers the possibility of strengthening individual competences and makes socio-psycho-biological conflicts tangible in a very direct way. Although music therapy is an established component of multimodal care and the inclusion of significant others in the therapy setting is recommended, there has been little clinical research on music therapy interaction processes in the family system. The researchers have designed a randomized controlled pilot trial (INMUT) that specifically addresses family interaction in a multi-person setting.

Methods: The examiners investigate the efficacy of music therapy interventions involving the parent-child dyad (INMUT-KB, n=16) compared to music therapy interventions involving only the child (MUT-K, n=16) and a waiting group without intervention (WG, n=10).

Research questions: 1) Does the parent-child interaction improves in mutual attunement, nonverbal communication, and emotional parental response? 2) Are there effects on quality of life, psychosocial and psychosomatic impairments, and system-related level of functioning? Evaluation tools: Primary goals will be assessed by the music therapy-based Assessment of parent-child interaction (APCI) pre and post. The secondary objectives will be assessed by self-reports in form of the psychometric questionnaires KINDL, Experience in Social Systems Questionnaire (EXIS), Burden Assessment Scale (BAS) and Symptom Checklist-K-9 (SCL-9K) pre, post and follow up.

Discussion: The investigators hope for an improvement of the primary and secondary endpoints through participation in music therapy as a basis for a needs-oriented accompaniment of families.

02

Conditions studied

  • Pediatric Cancer

Browse trials for

Keywords

  • pediatrics oncology
  • music therapy
  • children
  • family
  • significant others
03

In context

Neoplasms

10,818 studies on the registry are indexed under Neoplasms; 2,324 are open to participants now.

This study's planned enrollment of 52 is below the median of 60 across 7,703 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

University of Witten/Herdecke is the lead sponsor of 40 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 13 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria, Children:

  • cancer diagnosis
  • inpatient (e.g. GKH)
  • no cognitive and auditory dysfunction

Exclusion Criteria, Children:

  • Serious comorbidity with impairment of brain-organic functions
  • \<14
  • serious physical comorbidity that does not allow specific assessment of psychosomatic constructs with certainty
  • withdrawal of

Inclusion Criteria, Important Reference Persons:

  • e.g. father, mother, siblings

Exclusion Criteria, Important Reference Persons:

  • withdrawal of consent
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
52 participants (estimated)

Study arms

  • Experimental
    Interaction-focused Music Therapy with Children and Significant Others (INMUT-KB) (exp. group)

    Interaction-focused music therapy with children with cancer and their significant others, delivered by trained music therapists

    Behavioral: Interaction-focused Music Therapy with Children and Significant Others (INMUT-KB) (exp. group)

  • Experimental
    Music Therapy with Children (MUT-K) (exp. group)

    Interaction-focused music therapy with children with cancer without the involvement of significant others, delivered by trained music therapists.

    Behavioral: Music Therapy with Children (MUT-K) (exp. group)

  • Experimental
    Interaction-focused Music Therapy with Children and Significant Others (WG-KB) (control group)

    Study participants randomized to this group receive the intervention INMUT 10 weeks after the experimental groups.

    Behavioral: Interaction-focused Music Therapy with Children and Significant Others (WG-KB) (control group)

Interventions

  • BehavioralInteraction-focused Music Therapy with Children and Significant Others (INMUT-KB) (exp. group)

    Interaction-focused music therapy with children with cancer and their significant others, delivered by trained music therapists.

  • BehavioralMusic Therapy with Children (MUT-K) (exp. group)

    Interaction-focused music therapy with children with cancer without the involvement of significant others, delivered by trained music therapists.

  • BehavioralInteraction-focused Music Therapy with Children and Significant Others (WG-KB) (control group)

    Study participants randomized to this group receive the intervention INMUT 10 weeks after the experimental groups.

06

What researchers measure

Primary outcomes

  1. Assessment of Parent-Child Interaction (APCI)

    The APCI captures child-reference interaction using mutual attunement, nonverbal communication, and emotional parental response. The diagnostic music therapy intervention sessions are conducted and evaluated by external, blinded, APCI-certified raters.

    Time frame: Baseline, Change in 10th hour of intervention

Secondary outcomes

  1. KINDL-Children/YouthVersion, Modul Oncology

    The KINDL uses 40 items to assess the psychological well-being, social relationships, physical functioning, and daily activities during the daily activities within the last week.

    Time frame: Baseline, Change in 10th hour of intervention, Change in 3 months after intervention

  2. Symptom Checklist-K-9 (SCL-9k)

    The "Short Form Symptom Checklist" (SCL-9k) captures impairment using 9 statements about somatization, obsessiveness, social insecurity, depressiveness, anxiety, aggressiveness, phobic anxiety, paranoia, and psychoticism.

    Time frame: Baseline, Change in 10th hour of intervention, Change in 3 months after intervention

  3. Experience in Social Systems Questionnaire (EXIS)

    EXIS, the "Questionnaire on Experience in Private Social Systems", measures on basis of 12 items the degree of belonging, autonomy, accord, and confidence in the social system described as important within the past 2 weeks.

    Time frame: Baseline, Change in 10th hour of intervention, Change in 3 months after intervention

  4. Burden Assessment Scale (BAS)

    The BAS uses 19 items to survey personal stress, feelings of guilt, the need to interrupt and postpone important matters, and a changed and altered perspective of time in relation to the symptoms displayed by the ill relatives within the last 6 months.

    Time frame: Baseline, Change in 10th hour of intervention, Change in 3 months after intervention

  5. Wittener Ressources Questionnaire (WIRF)

    WIRF captures resources on the basis of three domains of coping with general life experiences, difficult situations in the past, and current problems, using 12 items each. We will use the domain of coping with general life esperiences.

    Time frame: Baseline, Change in 10th hour of intervention, Change in 3 months after intervention

  6. Goal Attainement Scale (GAS)

    GAS captures in free text the subjective goals of children and their significant others. These are classified using the Bern Inventory for Therapy (BIT-T): (1) coping with specific problems and symptoms, (2) interpersonal goals, (3) well-being, (4) existential issues, (5) personal growth, (6) residual category.

    Time frame: Baseline, Change in 10th hour of intervention, Change in 3 months after intervention

07

Study locations

3 of 3 sites recruiting
08

References and documents

Publications

  • Hunger C, Hilzinger R, Klewinghaus L, Deusser L, Sander A, Mander J, Bents H, Ditzen B, Schweitzer J. Comparing Cognitive Behavioral Therapy and Systemic Therapy for Social Anxiety Disorder: Randomized Controlled Pilot Trial (SOPHO-CBT/ST). Fam Process. 2020 Dec;59(4):1389-1406. doi: 10.1111/famp.12492. Epub 2019 Oct 27. PubMed 31657011 ↗
  • Hunger, C. (2020). Familienaufstellung als Einzelintervention im Gruppensetting bei chronisch-psychosozialen Konflikten: Randomisiert-kontrollierte Wirksamkeitsstudie mit Katamnesen von 2 Wochen bis 5 Jahre. Zeitschrift für Psychiatrie, Psychologie und Psychotherapie, 68(4), 263-273.
  • Hunger C, Bornhauser A, Link L, Geigges J, Voss A, Weinhold J, Schweitzer J. The Experience in Personal Social Systems Questionnaire (EXIS.pers): Development and Psychometric Properties. Fam Process. 2017 Mar;56(1):154-170. doi: 10.1111/famp.12205. Epub 2016 Feb 8. PubMed 26858173 ↗
  • Boyde C, Linden U, Boehm K, Ostermann T. The Use of Music Therapy During the Treatment of Cancer Patients: A Collection of Evidence. Glob Adv Health Med. 2012 Nov;1(5):24-9. doi: 10.7453/gahmj.2012.1.5.009. Epub 2012 Nov 1. PubMed 27257528 ↗
  • Ostermann, T., Boyde, C., & Linden, K. (2012). Music therapy in the treatment of cancer patients: A systematic review. BMC Complementary and Alternative Medicine, 12(Suppl1): P327.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05534282
Lead sponsor
University of Witten/Herdecke
Collaborators
Heidehof Foundation Stuttgart, Community Hospital Herdecke, Nordoff/Robbins Music Therapy Center Witten, Interprofessional Graduate Programm in Integrative Medicine IGIM
Responsible party
Constance Boyde (cand. Dr., University of Witten/Herdecke) — Principal investigator
First posted
Sep 9, 2022
Start date
Mar 1, 2023
Primary completion
Aug 31, 2024 (estimated)
Completion
Nov 30, 2024 (estimated)
Last update
May 9, 2024

Study contacts

Constance Boyde, cand. Dr.
Contact
constance.boyde@uni-wh.de
0049-2302/9267738
Christina Hunger-Schoppe, Prof. Dr.
Contact
christina.hunger-schoppe@uni-wh.de
0049-2302/9267907
Alfred Längler, Prof. Dr.
principal investigator · Gemeinschaftskrankenhaus Herdecke
Dominik Schneider, Prof. Dr.
principal investigator · Klinikum Dortmund
Michael Paulussen, Prof. Dr.
principal investigator · Vestische Kinderklinik Datteln

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion